Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase by Singhal, Anshika et al.
Regulation of homocysteine metabolism
by Mycobacterium tuberculosis
S-adenosylhomocysteine hydrolase
Anshika Singhal1, Gunjan Arora1, Andaleeb Sajid1, Abhijit Maji1, Ajay Bhat1, Richa Virmani1,
Sandeep Upadhyay2, Vinay K. Nandicoori2, Shantanu Sengupta1 & Yogendra Singh1
1CSIR-Institute of Genomics and Integrative Biology, Delhi-110007, India, 2National Institute of Immunology, Aruna Asaf Ali Marg,
New Delhi-110067, India.
Mycobacterium tuberculosis modulates expression of various metabolism-related genes to adapt in the
adverse host environment. The gene coding for M. tuberculosis S-adenosylhomocysteine hydrolase
(Mtb-SahH) is essential for optimal growth and the protein product is involved in intermediarymetabolism.
However, the relevance of SahH in mycobacterial physiology is unknown. In this study, we analyze the role
of Mtb-SahH in regulating homocysteine concentration in surrogate host Mycobacterium smegmatis.
Mtb-SahH catalyzes reversible hydrolysis of S-adenosylhomocysteine to homocysteine and adenosine and
we demonstrate that the conserved His363 residue is critical for bi-directional catalysis. Mtb-SahH is
regulated by serine/threonine phosphorylation of multiple residues by M. tuberculosis PknB. Major
phosphorylation events occur at contiguous residues Thr219, Thr220 and Thr221, which make pivotal
contacts with cofactor NAD1. Consequently, phosphorylation negatively modulates affinity of enzyme
towards NAD1 as well as SAH-synthesis. Thr219, Thr220 and Thr221 are essential for enzyme activity, and
therefore, responsible for SahH-mediated regulation of homocysteine.
S
-adenosylhomocysteine hydrolase (SahH) catalyzes reversible hydrolysis of S-adenosylhomocysteine
(SAH) and produces homocysteine and adenosine1 (Fig. 1A). Homocysteine is either used in the transsul-
furation pathway to synthesize cysteine or re-methylated to methionine for S-adenosylmethionine (SAM)
regeneration2. Adenosine is either deaminated to inosine or used in the synthesis of nucleotides by salvage
pathway2. Role of SahH in regulating the concentration of important metabolites such as SAH and homocysteine
has been studied in great detail in eukaryotes3–5. In humans, genetic defect in SAHH gene (encoding SAHH/
AdoHcy hydrolase) is accompanied by several impaired phenotypes including elevated levels of methionine and
homocysteine3. SAH catabolism by SahH helps in increased tolerance to salt stress in plants by maintaining the
synthesis of an osmolyte- glycine betaine4. Disruption of sahh in bacteria Rhodobacter capsulatus exhibits loss of
survival in minimal media, altered SAM and SAH levels and decreased bacteriochlorophyll synthesis5. Similarly,
SahH inhibitor neplanocin A increases SAH levels in Alcaligenes faecalis6. In Mycobacterium tuberculosis, the
levels of SAH and homocysteine are modulated in response to different carbon sources and drugs respectively7,8.
Themechanism underlying this regulation is still unknown. SahHmay have an important role in the regulation of
these metabolites in M. tuberculosis. sahh is essential for growth of M. tuberculosis9; however, the physiological
role(s) of enzyme as well as its regulation is largely unexplored.
SahH consists of two domains- a substrate-binding catalytic domain and a cofactor binding domain10. The
catalytic processes in both, SAH-hydrolytic and SAH-synthetic directions essentially require NAD1 as a cofac-
tor11.M. tuberculosis is the first prokaryote in which the structure of SahH has been elucidated12.M. tuberculosis
SahH (Mtb-SahH) forms a homotetramer with one NAD1 molecule bound to each subunit12. Residues involved
in catalysis as well as those involved in hydrogen-bonding with NAD1 are conserved inMtb-SahH. Interestingly,
a distinct feature was observed near the homocysteine-binding site in solvent access channel involving His363 of
Mtb-SahH12. In this study, we analyze the regulation of homocysteine concentration byMtb-SahH.We show the
role of the conserved residue His363 in enzyme activity. Subsequently, we study the regulation of SahH by serine/
threonine phosphorylation, as well as identify important phospho-acceptor residues which, interestingly, are also
involved in NAD1-binding. This study indicates that phosphorylation-mediated regulation of SahH is conserved
in mycobacteria and it can be a novel mechanism of regulating homocysteine metabolism.
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Results
Reversible catalysis of SAH by Mtb-SahH. To validate reversible
catalysis, Mtb-SahH was cloned in pProEx-HTc and purified as a
recombinant His6-tagged protein (HTc-SahH) from Escherichia coli.
SAH-hydrolytic activity of purified Mtb-SahH was assessed by a
colorimetric assay using Ellman’s reagent (DTNB) that detects the
product- homocysteine13. SahH requires NAD1 as a cofactor11 and its
NADH-bound form is inactive14. Since the purified protein contains
NAD1 as well as NADH14, there was no detectable activity in purified
protein in the absence of any added cofactor (data not shown).
Therefore, we prepared apo-SahH, reconstituted it with NAD1 to
obtain holo-SahH, which was used with increasing concentration of
SAH (0–100 mM) to analyze SAH-hydrolysis. An increase in SAH-
hydrolytic activity was observed with increasing amounts of SAH
(Fig. 1B), implying that holo-SahH was active. The reaction was
found to attain saturation at 80 mM of SAH after which the
enzyme activity did not increase further. The hydrolytic activity
also increased with increasing amounts of holo-SahH (10–400 mM)
(Supplementary Fig. S1). These results confirm SAH-hydrolytic
activity of Mtb-SahH.
To validate thatMtb-SahH is also active in reversible direction, we
analyzed its ability to synthesize SAH from homocysteine and aden-
osine. Mtb-SahH was incubated with [8-14C]-adenosine and homo-
cysteine and the reactions were carried out for 1 or 2 hours. Reaction
products were then resolved by thin layer chromatography (TLC)
and analyzed by autoradiography. Apo-SahH showed negligible
activity in the absence of NAD1 (Supplementary Fig. S2A), while
holo-SahH could synthesize considerable amounts of SAH (Fig. 1C).
Further, we observed that the activity increased with increasing con-
centration of holo-SahH (1–4 mM) (Supplementary Fig. S2B). Taken
together, these assays show that M. tuberculosis SahH is an active
enzyme that can catalyze reversible hydrolysis of SAH.
Figure 1 | Metabolic pathways and activity of Mtb-SahH. (A) Homocysteine metabolism and the role of SahH. SahH (green oval box) catalyzes
reversible hydrolysis of SAH to homocysteine and adenosine as shown by bi-directional arrows. Numbers in circles denote the enzymes present in M.
tuberculosis H37Rv as follows: 1- SahH (Rv3248c), 2- Cystathionine b-synthase (Rv1077), 3- Cystathionine c-synthase (Rv1079), 4- Adenosine kinase
(Rv2202c), 5- Adenylate kinase (Rv0733), 6- Adenosine deaminase (Rv3313c), 7- Methionine synthase (Rv2124c and Rv1133c), 8- S-adenosylmethionine
synthetase (Rv1392) and 9- Methyltransferases, which transfer methyl group (CH3) to substrate molecules. (B) SAH-hydrolytic activity of His6-SahH
purified from E. coli. 100 nM of holo-SahH was used with 0–100 mM of SAH. A reaction containing 100 mM SAH in the absence of enzyme (No enz.)
served as a control for spontaneous SAH-hydrolysis. OD was measured at 415 nm and plotted as a function of time (minutes). SahH activity increased
with increasing concentration of SAH. (C) SAH-synthetic activity of His6-SahH purified from E. coli. Reaction was performed for 2 hours using 4 mM of
holo-SahH and TLC image was analyzed by autoradiography (lane 1). SahH from Rabbit erythrocytes was used as a positive control (lane 3) and a negative
control was setup without the (lane 2). Adenosine (Ado) and SAH spots are indicated by arrows. After the densitometric analysis of spots, percent SAH
synthesis is plotted in lower panel. An extra spot above SAH-spot in lane 3 could be inosine due to slight contamination (,1%) of adenosine deaminase
enzyme in SahH (from rabbit erythrocytes purchased from a commercial source, Sigma) that deaminates adenosine to inosine. Corresponding retention
factors (Rf) were SAH (0.1), inosine (0.36) and adenosine (0.5).
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Role ofHis363 in SahH activity. SahH is one of the highly conserved
proteins in both eukaryotes and prokaryotes10. His363 is a conserved
residue inMtb-SahH, which based on the sequence (Supplementary
Fig. S3) and structural analyses, is proposed to act as a switch, that
opens to allow access to the substrate SAH11,12. His363 needs to flip-
out in order to accommodate homocysteine moiety of SAH12,
although its role in enzyme activity has not been proven experimen-
tally. To gain insight into this mechanism, His363 residue of Mtb-
SahH was mutagenized to alanine and the SahH-H363Amutant was
purified as a recombinant protein from E. coli. SAH-hydrolytic
assays were performed with equal amounts of wild type SahH
(SahH-WT) and SahH-H363A, where the mutant was found to be
completely inactive (Fig. 2A). To confirm the role of His363 in
catalysis we also checked the efficiency of H363A mutant to
synthesize SAH. SahH-H363A mutant showed reduced activity to
synthesize SAH, as compared to SahH-WT (Fig. 2B). These results
confirm that His363 does act as a key residue for SahH enzyme
activity.
Regulation of homocysteine concentration by SahH. SahH catalyzes
a reversible reaction where in vitro equilibrium favors the SAH-
synthetic direction, but under in vivo conditions, hydrolytic activity
is preferred as the products of this reaction (homocysteine and
adenosine) are constantly being used by downstream enzymes1. In
order to observe the favored direction of catalysis in mycobacteria, we
examined the role of SahH in the regulation of intracellular
homocysteine concentration in the surrogate host Mycobacterium
smegmatis. Any change in the expression or activity of SahH may
lead to an alteration in the concentration of homocysteine.Mtb-SahH
was over-expressed in M. smegmatis MC2 4517 using pYUBDuet
shuttle vector. Over-expression of Mtb-SahH was confirmed by
immunoblotting using antibodies generated against Mtb-SahH (Sup-
plementary Fig. S4). Total intracellular homocysteine concentration
was then measured in M. smegmatis. The homocysteine amounts
were 1.411 6 0.25 mmoles/1015 colony forming units (CFU) in M.
smegmatis (empty) and 1.346 6 0.18 mmoles/1015 CFU in M.
smegmatis harboring only the vector used for over-expression of
Mtb-SahH (Table 1). Over-expression of Mtb-SahH increased
homocysteine level to 6.363 6 2.06 mmoles/1015 CFU (Table 1 and
Fig. 2C). Thus, increase in levels of SahH in mycobacteria causes
increase in this critical metabolite.
Conservation of SahH inmycobacteria and its regulation by phos-
phorylation. Since SahH is a key enzyme involved in metabolism,
understanding its regulation will be helpful in revealing the
mechanisms underlying homocysteine metabolism. In a prior
study, during the analysis of intracellularly expressed proteins of
M. tuberculosis, multiple spots of Mtb-SahH were found with
distinct isoelectric points in two-dimensional electrophoresis,
suggesting post-translational modifications of this protein15.
Interestingly, Mtb-SahH was found to be a phosphorylated protein
in a large-scale phosphoproteome analysis ofM. tuberculosis16. Based
Figure 2 | Role ofHis363 in activity and effect of SahHon homocysteine concentration inM. smegmatis. (A) Role of His363 in SAH-hydrolytic activity.
Activities of 1.74 mM each of holo SahH-WT and holo SahH-H363A were compared. Graph shows increase in OD at 415 nm with time when SahH-WT
was used. No increase in OD at 415 nm was observed with SahH-H363A mutant. Error bars represent standard deviation (SD). (B) Role of His363 in
SAH-synthetic activity. Activities of 4 mM each of holo SahH-WT and holo SahH-H363A were compared. Autoradiograph of TLC shows SAH synthesis
in reactions containing SahH-WT while reduced product formation was seen in reactions containing SahH-H363A. Adenosine (Ado) and SAH spots are
indicated by arrows. (C) Histogram representing intracellular homocysteine concentration in M. smegmatis MC2 4517 with and without the over-
expression of Mtb-SahH. Homocysteine concentration was analyzed using UPLC and plotted as mmoles/1015 CFU. Homocysteine levels increased to
about six times in cells over-expressing SahH (see also Table 1). Error bars represent standard deviation of three independent experiments and * p, 0.05
as calculated by Student’s t-test.
www.nature.com/scientificreports
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on these earlier findings, we analyzed the phosphorylation status of
SahH in differentMycobacterium species. SahH showed high amino
acid sequence conservation in ten different species ofMycobacterium
genus including both pathogenic and non-pathogenic bacteria (Sup-
plementary Fig. S3). In order to assess conserved phosphorylation-
mediated regulation of SahH across different mycobacterial species,
we analyzed phosphorylation status of SahH inMycobacterium bovis
BCG and M. smegmatis. Native SahH from M. bovis BCG (Mbo-
SahH) was immunoprecipitated and its phosphorylation status was
analyzed. The identity of SahH in immunoprecipitated sample was
first confirmed by immunoblotting with anti-SahH antibodies
(Supplementary Fig. S5A). Phosphorylation was then confirmed by
immunoblotting with anti-phospho-threonine (anti-pThr) anti-
bodies as the major phosphorylated amino acid in M. tuberculosis
is Thr16.Mbo-SahHwas found to be phosphorylated (Fig. 3A). PknBc
(catalytic domain ofMtb-PknB17, 1–331 amino acids) and GST were
used as positive and negative controls, respectively. This result
demonstrates that SahH is a potential substrate of serine/threonine
protein kinases (STPKs) in M. bovis BCG.
Further, phosphorylation ofMtb-SahHwas confirmed inM. smeg-
matis. Mtb-SahH was over-expressed as a His6-tagged protein and
purified from M. smegmatis. Purified fraction (pSD5-SahH) was
Table 1 | Homocysteine concentration [(mmoles/1015 CFU) 6 SD] in M. smegmatis MC2 4517
M. smegmatis strains Empty (no vector) pYUBDuet vectora pYUBDuet:SahHa pYUBDuet:SahH-T219A/T220A/T221A
Homocysteine
concentration
1.411 6 0.251 1.346 6 0.176 6.363 6 2.057 1.030 6 0.258
ap value is 0.0136 as assessed by Student’s t-test.
Figure 3 | In vivo phosphorylation of SahH and characterization ofMsm-SahH. (A) In vivo phosphorylation of SahH inM. bovis BCG. Native SahH was
immunoprecipitated from M. bovis BCG and its phosphorylation was assessed by immunoblotting using anti-pThr antibodies. Upper panel shows
immunoblot and lower panel shows ponceau-stained membrane. PknBc and GST were used as positive and negative controls, respectively. The protein
band corresponding to SahH in Mbo-SahH was not visible on ponceau image but was found to be highly phosphorylated on Thr residues (See also Fig.
S5A). (B) In vivo phosphorylation of SahH in M. smegmatis. Mtb-SahH was cloned and over-expressed in M. smegmatis as a His6-tagged protein and
phosphorylation was assessed in purified fraction (pSD5-SahH) by immunoblotting using anti-pThr antibodies. Upper panel shows immunoblot and
lower panel shows ponceau-stained membrane. PknBc and PknBc-K40M were used as positive and negative controls, respectively (See also Fig. S5B).
(C) Detection of Msm-SahH by immunoblotting. Msm-SahH was over-expressed and purified from E. coli and analyzed by immunoblotting using
anti-SahH antibodies. Upper panel shows immunoblot and lower panel shows ponceau-stained membrane. Mtb-SahH and GST were used as positive and
negative control respectively. (D) Activity analysis of Msm-SahH purified from E. coli as a His6-tagged protein. 1.74 mM of holo Msm-SahH was used for
the activity analysis and OD at 415 nm is plotted as a function of time. Graph shows increase in SAH-hydrolytic activity over time.
www.nature.com/scientificreports
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phospho-enriched and immunoblotted with anti-SahH and anti-
pThr antibodies. The phospho-enriched sample contained multiple
protein bands and presence of SahH was confirmed by immunoblot-
ting with anti-SahH antibodies (Supplementary Fig. S5B). Protein
identity was also confirmed by mass spectrometry (data not shown).
Immunoblotting with anti-pThr antibodies showed that Mtb-SahH
is phosphorylated inM. smegmatis by native STPKs (Fig. 3B). PknBc
and PknBc-K40M18 (catalytically inactivemutant of PknB) were used
as positive and negative controls, respectively. These results together
confirm that SahH gets phosphorylated in vivo in different species
such as M. bovis BCG and M. smegmatis suggesting that SahH is a
conserved substrate of STPKs.
M. smegmatis sahhwas initially thought to be a pseudogene with a
frame-shift mutation, although later it was corrected and proved to
be a sequencing error19, still there was no conclusive experimental
proof of presence of active M. smegmatis SahH (Msm-SahH). We
therefore, cloned the gene coding forMsm-SahH in pProEx-HTc and
purified the protein from E. coli. In sequence analysis, this gene did
not show any frame-shift mutation and the sequence coded an ORF
of 485 amino acids (data not shown). Anti-SahH antibodies gener-
ated against Mtb-SahH were able to detect the purified Msm-SahH
(Fig. 3C). Also, Msm-SahH was found to be enzymatically active
(Fig. 3D) confirming conservation of SahH in M. smegmatis.
In vitro phosphorylation and dephosphorylation of Mtb-SahH.
Ser/Thr phosphorylation is a vital component of signaling machi-
nery of M. tuberculosis consisting of 11 STPKs (PknA to PknL) and
one Ser/Thr phosphatase (PstP)20. Out of 11 STPKs, only four (PknA,
PknB, PknG and PknL) are conserved in Mycobacterium leprae,
which has evolved after extensive gene decay and elimination,
leaving only the genes that are critical for survival21. pknA and
pknB (the genes coding for PknA and PknB, respectively) are
located in the same genomic region as pstP (the gene coding for
PstP)20. The gene coding for PknB is essential for the growth and
survival ofM. tuberculosis22 and PknB regulates several fundamental
processes like cell shape, cell division, metabolism, protein synthesis
and response to stress18,23–27. To assess the phosphorylation of SahH
by PknB, in vitro kinase assays were performed withMtb-SahH and
PknBc. As seen in the autoradiograph (Fig. 4A), Mtb-SahH was
found to be phosphorylated by PknBc. Phosphorylation was
specifically localized to the protein and not on the His6-tag as
evident after the cleavage of tag by TEV protease (Supplementary
Fig. S6). We also found that SahH is a target of multiple STPKs ofM.
tuberculosis (data not shown), which is consistent with earlier
observation16. The reversible regulation of Mtb-SahH by phospho-
rylation was confirmed by the dephosphorylation assay with PstPc
(catalytic domain of PstP28, 1–300 amino acids). SahH phospho-
rylated by PknBc was found to be dephosphorylated by PstPc in a
time-dependent manner (Fig. 4B). These experiments show that
SahH is a substrate of Mtb-STPK PknB and Ser/Thr phosphatase
PstP.
Phosphorylation of Mtb-SahH in the surrogate host E. coli. To
further substantiate PknB-specific in vitro SahH phosphorylation,
Mtb-SahH was co-expressed in E. coli with PknB in a dual
expression vector pETDuet-1. As a control, catalytically inactive
mutant PknB-K40M18 was co-expressed with Mtb-SahH instead of
PknB. To discern the in vivo phosphorylation of SahH, E. coli cells
containing the dual expression constructs were metabolically labeled
with 32P-orthophosphoric acid to label the phosphorylated proteins.
Figure 4 | Phosphorylation of Mtb-SahH by PknBc. (A) In vitro kinase assay of Mtb-SahH with PknBc. Upper panel shows autoradiograph with PknBc
alone (lane 1) and PknBc with SahH (lane 2). Lower panel shows the corresponding coomassie-stained gel image. As evident, SahH is phosphorylated by
PknBc. (B) In vitro dephosphorylation of Mtb-SahH by PstPc. SahH phosphorylated by PknBc was subjected to dephosphorylation by PstPc and
samples were taken for analysis at the indicated time points, for a total of 25 minutes. Upper panel shows autoradiograph and lower panel shows
coomassie-stained gel image. (C) Autoradiograph of metabolic labeling of SahH-P and SahH-UP. E. coli expressing SahH-P or SahH-UP was subjected to
metabolic labeling and autoradiograph is shown. SahH co-expressed with PknB (SahH-P) was observed to be phosphorylated as opposed to SahH
co-expressed with PknB-K40M (SahH-UP). (D) Phosphoamino acid analysis of SahH-P by 2D-TLE. Left panel shows ninhydrin-stained TLC plate and
right panel shows the corresponding autoradiograph. Residues pThr, pSer and pTyr have been encircled. As observed in the autoradiograph, only pThr is
detected in SahH phosphorylated by PknB. (E) Immunoblot analysis with anti-pThr antibodies. SahH-P and SahH-UP were purified and their
phosphorylation status was analyzed. Upper panel shows the immunoblot and lower panel shows ponceau-stained membrane. SahH-P was found to be
phosphorylated on Thr residues.
www.nature.com/scientificreports
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Ni1-NTA affinity pull-down was then used to extract SahH and
purified proteins were run on SDS-PAGE followed by autora-
diography. pETDuet-SahH:PknB (renamed SahH-P) was found to
be phosphorylated while pETDuet-SahH:PknB-K40M (renamed
SahH-UP) was not phosphorylated (Fig. 4C). To identify the
phosphorylated amino acid residues of SahH, phosphoamino acid
analysis was performed with purified SahH-P followed by two-
dimensional thin layer electrophoresis (2D-TLE). Phosphorylation
was present specifically on Thr residues (pThr) while neither
phospho-Ser (pSer) nor phospho-Tyr (pTyr) was detected on
SahH-phosphorylated by PknB in E. coli (Fig. 4D). To validate Thr
phosphorylation, SahH-P and SahH-UP were purified as His6-tag
proteins and analyzed for the phosphorylation by immunoblotting
using anti-pThr antibodies after their interaction with PknB or
PknB-K40M in E. coli cells. While, SahH-UP was found to be
unphosphorylated, SahH-P was found to be phosphorylated on
Thr residues (Fig. 4E). These experiments reaffirm that Mtb-SahH
is phosphorylated by PknB.
Identification and validation of phosphorylation sites. Purified
SahH-P and SahH-UP were subjected to mass-spectrometric
analysis to identify the phosphorylation sites. Five Thr and one Ser
residues were found to be phosphorylated on SahH by PknB in E.coli
(Fig. 5A). Among the phospho-sites, Thr216, Thr219, Thr220 and
Thr221 are present in the domain I, which is the substrate binding
catalytic domain. Thr257 and Ser376 are present in the domain II
which is the cofactor binding domain12. No phosphorylated residues
were identified on SahH-UP (data not shown).
To validate these phosphorylation sites of SahH, specific Ser and
Thr residues were mutated to alanine to generate phospho-deficient
variants of SahH which cannot accept a phosphate group. SahH-WT
and mutant proteins co-expressed with PknB in E. coli were thus
purified, analyzed for phosphorylation by immunoblotting and sub-
sequent densitometric analysis was plotted. Single site mutants of
Thr219, Thr220, Thr221 and Thr257 residues showed 25–50% loss
in phosphorylation signal except SahH-T216Awhich showed hyper-
phosphorylation (Fig. 5B, Supplementary Fig. S7A). No considerable
loss in phosphorylation was observed in SahH-S376A by immuno-
blotting using anti-pSer antibodies (data not shown). Multiple Thr
mutants of SahH were then generated and analyzed in the same way.
Maximum loss (approximately 90%) in the phosphorylation signal
was obtained in the triple mutant of Thr219, Thr220 and Thr221
(SahH-T219A/T220A/T221A) (Fig. 5C, Supplementary Fig. S7B).
To substantiate the phosphorylation of these three residues, E. coli
containing SahH-WT or SahH-T219A/T220A/T221A, both co-
expressed with PknB, were subjected to metabolic labeling as
discussed in previous section and proteins were analyzed by auto-
radiography. The SahH-T219A/T220A/T221A mutant showed
approximately 60% loss in phosphorylation intensity when com-
pared to SahH-WT (Fig. 5D, Supplementary Fig. S8). Thus,
Figure 5 | Analysis of phosphorylation sites on Mtb-SahH. (A) Diagrammatic representation of phosphorylation sites at SahH-P identified by mass-
spectrometry. Five Thr (Thr216, Thr219, Thr220, Thr221 and Thr257) and one Ser residues (Ser376) were identified and labeled above the respective
domains of SahH. Domain I is shown in blue color and domain II is shown in white color. (B) and (C) Histograms depicting relative phosphorylation of
SahH and its single or multiple Thr mutants, respectively. Purified SahH-WT and its mutants were analyzed by immunoblotting with anti-pThr
antibodies. Percent relative phosphorylation was calculated considering the phosphorylation intensity of SahH-WT as 100%. Corresponding
immunoblots are shown in Supplementary Fig. S7A and S7B. (D) Metabolic labeling of SahH-WT and SahH-T219A/T220A/T221A mutant. Histogram
depicting densitometric analysis of autoradiograph of metabolically labeled proteins purified from E. coli. Percent relative phosphorylation is shown
considering phosphorylation intensity of SahH-WT as 100%. Corresponding autoradiograph and coomassie-stained gel image is shown in
Supplementary Fig. S8.
www.nature.com/scientificreports
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Thr219, Thr220 and Thr221 are themajor sites of phosphorylation at
SahH by PknB. Amutant of all the four Thr residues at sites 216, 219,
220 and 221 (SahH-T216A/T219A/T220A/T221A) was also gener-
ated and found to be hyperphosphorylated (Supplementary Fig.
S7B). The mutation of Thr at the position 216 could have resulted
in structural perturbations leading to opening of tertiary structure,
which served as a non-specific substrate for the phosphorylation. As
a result, both SahH-T216A and SahH-T216A/T219A/T220A/T221A
mutants were hyperphosphorylated (Fig. 5B and Supplementary
Fig. S7B).
Phosphorylation-mediated changes in SahH activity. The major
phospho-sites at SahH (Thr219–Thr221) obtained in our study with
PknB are also involved in NAD1 binding12. Therefore, we chose to
analyze the phosphorylation-mediated changes in the affinity of
SahH towards NAD1. To assess the kinetic differences in the
activity of SahH due to its phosphorylation, SAH-hydrolytic activi-
ties were measured with the apo-forms of SahH-P and SahH-UP
using increasing concentration of NAD1. Phosphorylation of Mtb-
SahH by PknB in E. coli did not affect the Vmax of SAH-hydrolysis
although the Km for cofactor NAD1 increased significantly (Fig. 6A).
While the Km of unphosphorylated SahH was 0.31 6 0.042 mM,
phosphorylation significantly increased it to 1.08 6 0.122 mM
(Table 2). Thus, phosphorylation decreased the affinity of SahH
for NAD1, confirming that the Thr219–Thr221 residues play a
decisive role in NAD1 binding. Similar negative effect of phospho-
rylationwas observedwhen the enzyme activity of SahHwas assessed
in synthetic direction. SahH-P was less efficient in the synthesis of
SAH using adenosine and homocysteine (Fig. 6B). Densitometric
analysis indicated that SahH-P was only 50% efficient in the
synthesis of SAH as compared to SahH-UP (Fig. 6C).
Since themajor sites of phosphorylationwere found to be Thr219–
Thr221, we analyzed the enzyme activity of SahH-T219A/T220A/
T221Amutant.We hypothesized that if the side-chains of these three
Thr residues are involved in NAD1 binding, then the mutant should
not be able to bind the cofactor.We found that SahH-T219A/T220A/
T221A mutant had no SAH-hydrolytic activity when compared to
SahH-WT protein (Fig. 6D), supporting our hypothesis. These
results show the importance of Thr219–Thr221 residues and their
phosphorylation in regulating SahH activity.
Structural analysis of NAD1 binding. To further understand the
phosphorylation-mediated changes in the cofactor binding, we
analyzed the available crystal structure of Mtb-SahH (PDB ID:
2ZIZ) with respect to the NAD1 binding. NAD1 binds to the
domain II of SahH (Fig. 7A) but still makes close contacts with the
three Thr residues at positions 219, 220 and 221 of domain I (Fig. 7B).
As shown in the figure, the side-chain oxygen atoms (OG1) of all the
three Thr residues were within 5 A˚ reach of the oxygen atom (O2D)
at the C-29 of the ribose moiety containing the nicotinamide of
NAD1. The region encompassing the Thr219, Thr220 and Thr221
residues of SahH was then enlarged to show their interaction with
Figure 6 | Effect of phosphorylation on enzyme activity ofMtb-SahH. (A) Effect of phosphorylation on SAH-hydrolytic activity. Michaelis-Menten plot
of SahH-P and SahH-UP is shown with concentration of NAD1 at horizontal axis. Phosphorylation of SahH is accompanied by increase in Km and no
change in Vmax (see also Table 2). (B) Effect of phosphorylation on SAH-synthetic activity. Autoradiograph of TLC is shown with reactions containing
4 mM each of SahH-P, SahH-UP and no enzyme. Intensity of SAH spot decreases when SahH-P is used as compared to SahH-UP. (C) Histogram showing
percent SAH synthesis by SahH-P and SahH-UP as observed in (B). SahH-P is only 50% active in synthesis of SAH. Error bars represent SD of three
independent results. *** p value equal to 0.001 as calculated by Student’s t-test. (D) Role of Thr219, Thr220 and Thr221 in SAH-hydrolytic activity.
Activities of 1.74 mM each of holo SahH-WT (SahH-P) and holo SahH-T219A/T220A/T221A (marked as SahHtri) purified from E. coli were compared.
Graph shows increase in OD at 415 nm of SahH-P with time while SahHtri does not show any detectable activity.
Table 2 | Kinetic parameters of SahH
Kinetic parametersa SahH-P SahH-UP
Specific activity (pmoles/
mg/min) 6 SE
11.42 6 0.322 10.47 6 0.215
Km (mM) 6 SEb 1.083 6 0.1218 0.3152 6 0.04249
aValues represent mean of three independent experiments with standard error (SE).
bp value is 0.004 as assessed by Student’s t-test.
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NAD1 (Fig. 7C). We next used UCSF Chimera to simulate the
presence of pThr at the positions 219, 220 and 221. Phospho-
rylation imparts two negative charges to the side-chain of each Thr
by adding a phosphate group containing three oxygen atoms
(Fig. 7D). This charge possibly disrupts the electrostatic interaction
of the protein with NAD1. Although NAD1 may still bind to SahH,
the efficiency with which it binds may greatly diminish. Also, to
accommodate the phosphate group, additional structural pertur-
bation may occur leading to interference with NAD1 binding. This
analysis explains the possible reasons for the decrease in affinity of
SahH-P for NAD1 and loss in activity of SahH-T219A/T220A/
T221A mutant.
Validation of SahH phosphorylation sites in M. smegmatis. To
further validate the role of Thr219–Thr221 residues in SahH
phosphorylation, we mutated these residues simultaneously in
pYUBDuet-SahH and over-expressed SahH-T219A/T220A/T221A
in M. smegmatis MC2 4517. Over-expression was confirmed by
immunoblotting using anti-SahH antibodies (Supplementary Fig.
S4). We used two-dimensional gel electrophoresis to resolve the
isoforms of SahH after the mutation of three contiguous Thr
residues. After this, the different isoforms of SahH were analyzed
by immunoblotting using anti-SahH antibodies. We identified four
isoforms of SahH-WT, separated according to their isoelectric points
(Fig. 8A). Interestingly, one isoform was lost when SahH-T219A/
T220A/T221A mutant was used indicating loss of phosphory-
lation. This shows that the Thr219–Thr221 residues are important
phosphorylation sites of Mtb-SahH in M. smegmatis.
Importance of Thr219–Thr221 in regulating homocysteine levels.
Wenext used SahH-T219A/T220A/T221A as a phospho-deficient as
well as enzymatically inefficient derivative to study the role of SahH
in regulating homocysteine concentration. Homocysteine amounts
were measured in M. smegmatis MC2 4517 with over-expression of
SahH-T219A/T220A/T221A. No measurable alteration in homocy-
steine levels were observed in cells over-expressing SahH-T219A/
T220A/T221A mutant as compared to vector-alone (Table 1 and
Fig. 8B), while SahH-WT increased homocysteine concentration
(Table 1 and Fig. 2C). These results validate the role of Thr219–
Thr221 residues in SahH-mediated regulation of homocysteine
concentration in vivo.
Discussion
Homocysteine is a key intermediate in the synthesis of metabolites
such as methionine, cysteine, SAM, SAH and adenosine (Fig. 1A).
Sulfur-containingmetabolites- methionine and cysteine are required
for the protein synthesis while SAM is essential for the one-carbon
metabolism. In M. tuberculosis, transsulfuration pathway helps in
conversion of methionine to cysteine where homocysteine is an
intermediate29. Adenosine ismetabolized via the purine salvage path-
way and proteins involved in this pathway are considered to be drug
targets inM. tuberculosis30. Thus, homocysteine stands at an import-
ant metabolic junction where it helps in regulating the levels of
crucial metabolites. Although the genes required in these metabolic
reactions have been identified inM. tuberculosis, there is no informa-
tion on regulation of the homocysteinemetabolism. Here, we present
Figure 7 | Structural analysis of SahH and itsmajor phosphorylation sites. (A) Cartoon representation of Mtb-SahH bound to NAD1 cofactor. Both the
domains of SahH have been labeled. Thr219–Thr221 residues have been colored (magenta) to mark their proximity with NAD1 (purple). Other color
representations are: helix (cyan), strand (yellow) and turn (red). (B) Region depicting interaction of NAD1 (green) with Thr219–Thr221. Side
chains of Thr residues are shown in orange color. Distances of side-chain oxygen of Thr residues from oxygen of NAD1 are: 2.855 A˚ (Thr219), 4.239 A˚
(Thr220) and 3.155 A˚ (Thr221). Other color representations are according to that in (A). (C) and (D) Stick diagram representation of Thr219–Thr221
residues with NAD1. Side-chain oxygen molecules of Thr residues were modified to attach a phosphate group with two negative charges in (D). Color
representations are as follows: Thr219–Thr221 (red), NAD1 (green), Phosphorus (yellow) and Oxygen (white).
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the evidence for the role of SahH in homocysteine metabolism, its
reversible enzyme mechanism and role of phosphorylation in its
regulation.
Our first objective was to characterize reversible enzyme activity of
Mtb-SahH. NAD1 was found to be a requisite for both SAH-hydro-
lytic and SAH-synthetic activities. NAD1-bound SahH was active
and did not require any other cofactor or metal ion. Further, loss
in SAH-hydrolytic and decrease in SAH-synthetic activity by H363A
mutation strengthens the earlier structural observation, where
His363 needs to flip out in order to accommodate ethylthioadenosine
(ETA, a partial analog of SAH)12. His363 is thus a critical residue for
enzyme activity.
We further analyzed functional conservation of SahH by mea-
suring its effect on homocysteine concentration. In earlier studies,
attempts to measure homocysteine-thiolactone in absence of exo-
genous homocysteine supplements could detect only very low levels
inM. smegmatis31. Even using mass spectrometry based techniques,
the sensitivity of detecting endogenous homocysteine was very low
and it is only the upregulation that was reported in the presence of
drug8. In our study, we used Ultra-high performance liquid chro-
matography (UPLC) to separate the thiol-containing molecules in
combination with a sensitive method of fluorescence-based detec-
tion. We were able to detect homocysteine in concentrated cell-free
extracts ofM. smegmatis. We found that concentration of homocys-
teine in M. smegmatis was indeed very low (Table 1) and over-
expression of SahH increases homocysteine levels to about six times.
This increase was in accordance with our in vitro results where
SAH hydrolysis augmented when SahH amounts were increased.
Over-expression of SahH in M. smegmatis led to increased SAH-
hydrolysis resulting in elevated homocysteine levels. This also indi-
cates that the probable favorable direction of catalysis in vivo is
SAH-hydrolysis; however, further investigations are required to con-
firm this hypothesis. SahH may regulate concentration of metabo-
lites like homocysteine, adenosine and SAH in the cell and any
change in its activity may perturb their concentration in the cell.
As discussed in later sections, our study suggests that SahH activity
can be regulated by phosphorylation of critical residues involved in
NAD1 binding.
We investigated the phosphorylation-mediated regulation of SahH
using M. tuberculosis PknB as a representative of the M. tuberculosis
STPKs. We observed that Mtb-SahH is a substrate of PknB among
other kinases. Since reversible regulation is a defining characteristic of
STPK-mediated phosphorylation, we checked dephosphorylation of
SahH using PstPc. SahH was found to be dephosphorylated by PstPc
in a time-dependent manner. Phosphorylation of SahH was also
evaluated in the E. coli dual expression system co-expressing SahH
and PknB. A convincing way to look at in vivo phosphorylation is
metabolic labeling using 32P-orthophosphoric acid. In this experi-
ment SahH-P (phosphorylated by PknB) was phosphorylated while
SahH-UP (co-expressed with PknB-K40M) was unphosphorylated.
Phosphoamino acid analysis helped us to identify the phospho-resi-
dues in SahH. In this analysis, Thr residues were found to be phos-
phorylated. SahH was then purified (SahH-P and SahH-UP) from E.
coli where SahH-P was found to be phosphorylated at Thr residues
while SahH-UP was unphosphorylated. These experiments con-
firmed that SahH is modified by reversible Ser/Thr phosphorylation
mediated by PknB and PstP.
Mass spectrometry analysis revealed that PknB phosphorylates
SahH on multiple Ser/Thr residues. Interestingly, three Thr residues
(Thr219, Thr220 and Thr221) were also identified by Prisic et al. in
M. tuberculosis phosphoproteome16. This indicates that PknB is
likely to be the kinase responsible for SahH phosphorylation in M.
tuberculosis. Also, four different isoforms of Mtb-SahH were iden-
tified when it is purified from M. smegmatis. This suggests that M.
smegmatis STPKs phosphorylate Mtb-SahH on multiple residues
reaffirming ourmass spectrometry results.Multiple phosphorylation
events at a single protein are a common phenomenon in M. tuber-
culosis signaling. InM. tuberculosis phosphoproteome 301 phospho-
proteins were identified with 516 sites, implying that there are several
proteins that are phosphorylated on multiple sites16. The multiple
sites of phosphorylation individually contributed almost equally to
total phosphorylation at SahH as loss in any single residue does not
completely abrogate the phosphorylation intensity. But, when mul-
tiple Thr residues were mutated to alanine, a triple mutant SahH-
T219A/T220A/T221A showed maximum loss in phosphorylation.
Importance of these three Thr residues in phosphorylation was also
seen in vivo by metabolic labeling of E. coli expressing SahH-T219A/
T220A/T221A and PknB. Here again, SahH-T219A/T220A/T221A
mutant showed significant loss in phosphorylation.
SahH was found to be a conserved protein with high sequence
identity among mycobacterial species and the conservation of
Thr219–Thr221 residues is noticeable. In light of this observation,
we reveal that phosphorylation of SahH is also a conserved phenom-
enon inMycobacterium species. Native SahH fromM. bovis BCG was
found to be phosphorylated. Also, recombinantMtb-SahH was found
to be phosphorylated in M. smegmatis suggesting a common phos-
phorylation-mediated regulatory mechanism of SahH. Since Thr219–
Thr221 residues were proposed to be involved in NAD1 binding12, we
suspected that multiple phosphorylated residues on SahH may affect
its enzymatic activity. Therefore, we measured kinetic parameters of
SahH-P and SahH-UP in SAH-hydrolytic direction. Phosphorylation
accompanied increase in Km indicating decrease in affinity towards
NAD1, the essential cofactor of SahH. Since NAD1 is required for
activity in both the directions, phosphorylated SahH was found to be
Figure 8 | Validation of Thr219–Thr221 as phosphorylation sites and
role in homocysteine regulation. (A) Validation of Thr219–Thr221 as
phosphorylation sites in M. smegmatis. SahH-WT and SahH-T219A/
T220A/T221A were purified from M. smegmatis, separated by two-
dimensional PAGE and immunoblotted with anti-SahH antibodies. For
clarity only the region containing SahH isoforms has been shown and
different isoforms have been encircled. As seen, one isoform is lost in
SahH-T219A/T220A/T221A. (B) Role of Thr219–Thr221 residues in
regulating homocysteine concentration. Histogram shows intracellular
homocysteine concentration in M. smegmatis MC2 4517 with and without
the over-expression of SahH-T219A/T220A/T221A (marked as SahHtri).
Homocysteine concentration was analyzed using UPLC and plotted as
mmoles/1015 CFU. Homocysteine levels were found to be unaffected by
SahH-T219A/T220A/T221A (see also Table 1). Error bars represent SD of
three independent results.
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only 50% efficient in SAH-synthesis as compared to unphosphory-
lated SahH. Loss in activity of SahH-T219A/T220A/T221A mutant
reinforced the role of Thr219–Thr221 residues in NAD1 binding.
NAD1 binds in a pocket constituted by domain II, which is a
Rossmann fold, but alsomakes electrostatic interactions with residues
in domain I12. We analyzed this interaction and observed that the
distance between side chains of Thr219–Thr221 residues and ribose
oxygen of NAD1 is # 5 A˚. Phosphorylation of Thr219–Thr221
modifies its interaction with NAD1 and thus modulates activity of
SahH. We also simulated the replacement of Thr219–Thr221 resi-
dues with pThr by modifying the atoms in already available structure
of SahH. It was clear that there would be hindrance in the binding of
NAD1 once the residues at these positions are phosphorylated.
Interestingly, Thr219–Thr221 residues are also important for SahH-
mediated regulation of homocysteine concentration as SahH-T219A/
T220A/T221A mutant does not upregulate homocysteine concentra-
tion in M. smegmatis.
In E. coli, acetate has been proposed to inhibit re-methylation of
homocysteine to methionine leading to elevated intracellular homo-
cysteine concentration which is toxic to the cell33,34. Although such
inhibitory effect of homocysteine needs to be elucidated in mycobac-
teria, our results indicate that exogenous homocysteine retards the
growth of M. smegmatis (data not shown). Phosphorylation of SahH
may be used in certain conditions to lower its activity and conse-
quently prevent upsurge of homocysteine concentration. Interes-
tingly, SahH phosphorylation was found to be induced in the presence
of acetate16. However, further investigations are required to assess
the role of SahH and its phosphorylation in homocysteine-mediated
toxicity.
Loss of NAD1 binding either by mutation of critical amino acid
residues (Thr219–Thr221) or by phosphorylation leads to decreased
SahH activity and the lattermechanismmay be used bymycobacteria
to fine tune the homocysteine concentration in the cell. Recently,
another report had shown that phosphorylation of M. tuberculosis
SahH by PknA affects Vmax of SAH-hydrolytic activity32. Thr2 and
Thr221 were identified as phosphorylation sites but the mechanism
by which phosphorylation at these sites decreases Vmax remains
obscure. Here we not only reveal the effect of phosphorylation on
SahH activity but also provide the evidence that phosphorylation
affects NAD1 binding and thus has an overall negative effect on
catalysis. We find a novel regulator of homocysteine concentration
in mycobacteria and suggest a mechanism that governs its modu-
lation. SahH, a highly conserved protein, is regulated by phosphor-
ylation and the phenomenon is conserved across Mycobacterium
species. The regulation of SahH by phosphorylation is an important
phenomenon as it governs concentration of key metabolites.
Methods
Bacterial strains and genemanipulations. E. coli cells were grown andmaintained in
LBmedium as described35.M. smegmatisMC2 155,M. smegmatisMC2 451736 (kindly
provided by Dr. Rajesh S. Gokhale) and M. bovis BCG were grown in Middlebrook
7H9 broth supplemented with 0.5% glycerol, 10% ADC, 0.05% Tween-80. The gene
coding for SahH (rv3248c andmsmeg_1843) was PCR amplified fromM. tuberculosis
H37Rv and M. smegmatis MC2 155 genomic DNA, respectively and cloned in
pProEx-HTc, pETDuet-1 (MCS-1), pSD537 and pYUBDuet38 vectors. Gene coding
for PknB or PknB-K40M (full-length, 1–626 aa) was inserted in MCS-2 of pETDuet-
127,39. Cloning of PknBc, PknBc-K40M and PstPc in pProEx-HTc was performed as
explained earlier40. pETDuet-SahH or pYUBDuet-SahH was used as template to
generate mutations using QuikChange XL-site directed mutagenesis kit, according to
manufacturer’s instructions (Stratagene). Tables 3 and 4 provide the detailed
information about plasmid constructs and primers used throughout this study.
Protein expression and purification. For expression of His6-tagged proteins from
pProEx-HTc or pETDuet-1, BL21 (DE3) cells were transformed with recombinant
plasmids. Proteins were expressed and purified as described earlier40. The purified
proteins were analyzed by SDS-PAGE and concentrations were estimated by
Bradford assay (Bio-Rad).
Enzymatic assay of SahH. E. coli-purified His6-SahH and its mutants were subjected
to ammonium sulfate precipitation to remove bound nucleotides, using the protocol
of Gomi et al.41. Detailed protocol is described in Supplementary methods. The ‘apo’
forms of protein thus obtained were free of NAD1 cofactor. To reconstitute the active
‘holo’ form, enzymes were incubated with 1 mM b-NAD1 for 30 minutes at 4uC in
buffer A (50 mM potassium phosphate buffer [pH 7.0] and 1 mM EDTA).
Enzyme activity was measured in hydrolytic direction using a colorimetric assay13
with 0–100 mMSAH. Reaction buffer contained 100 mMEllman’s reagent (or DTNB,
Sigma) and 1 unit of adenosine deaminase (Sigma) in buffer A. Reaction was started
by adding 100 nM of holo-form of SahH, unless otherwise indicated. For the deter-
mination of Km and Vmax, 1.74 mMof apo-forms of SahH-P and SahH-UP were used
with 0–10 mM b–NAD1. The reaction was allowed for 25 min at 37uC and OD was
measured at 415 nm (microplate reader 680 XR, Bio-Rad). Absorbance units were
converted to activity units (pmoles/mg/min). Km and Vmax values were obtained by
non-linear regression analysis using GraphPad Prism software. Values from three
independent experiments were presented as mean 6 standard error.
Enzymatic activity in synthetic direction was measured as described42. Briefly, 1–
4 mM of holo-SahH was incubated with 25 mCi [8-14C] adenosine (American
Radiolabeled Chemicals, St. Louis, MO; specific activity 53.5 mCi/mmol) and 5 mM
DL-homocysteine (Sigma) in 20 mM potassium phosphate buffer [pH 7.0] (with
1 mMEDTA and 1 mMDTT). Reaction samples were incubated at 37uC for one and
two hours followed by boiling at 100uC for 5 minutes. 10 ml sample from the total
reaction volume of 50 ml was spotted on cellulose thin-layer chromatography (TLC)
plates (Merck) and developed with butanol:methanol:water:NH4OH (6052052051,
v/v). Plates were dried and analyzed by autoradiography using Personal Molecular
Imager (PMI, Bio-Rad). Densitometric analysis was done using Quantity OneH 1-D
analysis software (Bio-Rad). Percent SAH synthesis was calculated as fraction of
substrate adenosine converted to SAH.
Homocysteine measurement.M. smegmatisMC2 4517 cells were grown to OD600 of
0.6–0.8 and induced with 1 mM IPTG and 0.2% acetamide for 48 hours. Cells were
harvested and washed three times with sterile water. Harvested cells were dissolved in
sterile water and lysed by bead beating using 0.1 mm Zirconium beads. Cell debris
was removed by centrifugation and cell-free lysate was processed for homocysteine
measurement as described43,44. Briefly, 100 ml of cell lysate was treated with 35 ml of
1.43 M Sodium borohydride dissolved in 0.1 N NaOH (to reduce the disulfide
bonds). Then, 10 ml of n-amyl alcohol was added followed by addition of 35 ml of 1 N
HCl. To this, 50 ml of 7 mM bromobimane (B4380, Sigma) dissolved in 5 mM
sodiumEDTA [pH 7.0] was added (to conjugate the reduced thiols with fluorophore).
The solution was incubated at 42uC for 12–15 minutes followed by incubation at
room temperature for 30–45 minutes. 50 ml of 1.5 M perchloric acid was used to
precipitate proteins. Supernatant was neutralized with 6 ml of 2 M tris base. 4 ml of
derivatized sample was injected into a 100 3 4.6 mm, 1.8 micron Eclipse plus C18
column using Agilent-1260 Ultra-high performance liquid chromatography (UPLC).
Columnwas equilibrated with 90% buffer 1 (5%methanol and 0.86% acetic acid) and
10% Buffer 2 (100% methanol). Thiols were eluted from the column with linear
Table 3 | List of plasmid constructs used in this study
Plasmid construct Description Reference or source
pProEx-HTc E. coli expression vector with N-terminal His6-tag Invitrogen
pProEx-HTc-SahH Expression of His6-SahH in E. coli This study
pProEx-HTc-PknBc Expression of His6-PknBc (cytosolic domain) in E. coli 40
pProEx-HTc-PstPc Expression of His6-PstPc (cytosolic domain) in E. coli 40
pETDuet-1 E.coli dual expression vector containing His6-tag in MCS-1 and S-tag in MCS-2 Novagen
pETDuet-SahH Expression of His6-SahH in MCS-1 in E. coli This study
pETDuet-PknB Expression of MBP-PknB in MCS-2 in E. coli 27, 39
pSD5 Mycobacterial expression vector with Kanamycin resistance 37
pSD5-SahH Expression of His6-SahH in M. smegmatis MC2 155 This study
pYUBDuet Inducible shuttle vector for expression of proteins in M. smegmatis MC2 4517 38
pYUBDuet-SahH Expression of SahH under IPTG-inducible promoter in M. smegmatis MC2 4517 This study
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gradient of both buffers (from 90%Buffer 1510%Buffer 2 to 0%Buffer 15100%buffer
2 in 7 minutes), with flow rate of 0.7 ml/min. Standard curve was generated with
known concentrations of homocysteine (0.195–3.125 mM). Results were quantified
by taking the area for the homocysteine-bromobimane peak and calculating its
concentration using a regression equation derived from the standard curve.
Homocysteine concentration was represented as mmoles/1015 CFU and results from
three independent experiments were plotted as mean 6 standard deviation.
Generation of polyclonal antibodies for SahH in mouse and immunoblotting.
Affinity purified His6-SahH was used for antibody generation (see Supplementary
methods). Standard protocols for western blotting were followed as described
earlier40. The antibodies and dilutions used were- anti-pThr antibody (Monoclonal,
Cell Signaling) 1520,000 dilution, anti-pSer antibody (Abcam) 1520,000 dilution,
anti-SahH antibody 1520,000 dilution and HRP-conjugated anti-mouse IgG
antibody (Bangalore Genei) 1520,000 dilution. The blots were developed using
ImmobilonTM western chemiluminescent HRP substrate kit (Millipore) according to
manufacturer’s instructions. During analysis of Thr mutants for loss in
phosphorylation, densitometric analysis of bands was done using alphaimager 3400
(Alpha Innotech Corporation, San Leandro, California, USA) and normalized to their
corresponding ponceau images. The relative loss in phosphorylation was calculated
by considering the phosphorylation of SahH-WT as 100%.
Immunoprecipitation of SahH.To assess the phosphorylation status of native SahH,
M. bovis BCG was grown till the OD600 5 1. Cells grown in 10 ml media were
harvested and resuspended in 1X PBS containing protease inhibitor cocktail followed
by lysis using bead-beating. Native SahH was immunoprecipitated from 2 mg whole
cell lysate using anti-SahH antibodies following the protocol as described by the
manufacturer (PierceH Crosslink Immunoprecipitation Kit). The
immunoprecipitated sample was run on SDS-PAGE, analyzed by immunoblotting
using anti-pThr and anti-SahH antibodies.
Purification of SahH from M. smegmatis. For purification of His6-SahH from M.
smegmatis electroporated with pSD5-SahH, similar protocol was followed as
described earlier27. The purified protein was phosphoenriched, concentrated and
utilized for immunoblotting. Identity of SahH was also confirmed by mass-
spectrometric analysis (TCGA, New Delhi). For purification of pYUBDuet-SahH,
plasmid constructs were electroporated in M. smegmatis MC2 4517 and
transformants were selected on 7H10 agar plates containing Kan and Hyg.
Purification procedures were the same as with pSD5-SahH except that the cultures
were induced with 1 mM IPTG.
In vitro kinase assays and phosphatase assays. In vitro phosphorylation of 4–5 mg
SahH by PknBc (1–2 mg) was carried out as described45 using 2 mCi [c-32P] ATP. For
the visualization of phosphorylation signal on cleaved proteins, removal of
recombinant tag was achieved by a previous protocol27. In vitro dephosphorylation
assays were carried out by adding PstPc (1 mg) as described by Sajid et al.46. In all the
assays proteins were separated by 10–12% SDS-PAGE and analyzed by PMI.
Metabolic labeling in E. coli. E. coli (BL21-DE3) transformants harboring either
pETDuet-SahH:PknB, pETDuet-SahH:PknB-K40M or pETDuet-SahH-T219A/
T220A/T221A:PknB were used for metabolic labeling as described by Sajid et al46.
Extracted samples were analyzed by autoradiography using PMI. Densitometric
analysis of autoradiograph-signals was done using alphaimager 3400 and normalized
to amount of protein as seen in their respective coomassie-stained images.
Phosphoamino acid analysis. For phosphoamino acid analysis, metabolically labeled
SahH-P was used and similar protocol was followed as previously described45,47.
Detailed protocol is described in Supplementary methods.
Identification of phosphorylation sites at SahH-P. For identification of
phosphorylation sites, SahH-P and SahH-UP (3 mg) was run on 12% SDS-PAGE,
stained with coomassie, de-stained and band corresponding to SahH-P was excised
from the gel and washed with MilliQ water. The samples were processed for
identification of phosphorylation sites by using Thermo-Finnagen LTQ electrospray
instrument (Proteomics Core Facility, Children’s Hospital, Boston, USA). Detailed
sample processing protocol has been described earlier46.
Sequence and structural analysis of proteins.Amino acid sequence analysis of SahH
was done using clustalW248, using ten different species of Mycobacterium. Available
structure of Mtb-SahH was downloaded from PDB website (PDB ID: 2ZIZ) and
Table 4 | list of primers used in this study
Name of the primera Primer sequence (59R39)b
SahH pETDuet F TGAGCCCCCAAAGGCGGCCGCAGCCCCTATGACCGGAA (NotI)
SahH pETDuet R GTCTGCTCGCGGGGCGGCCGCACTCAGTAGCG (NotI)
SahH HTc F GAGCCCCCAAAGAAGGATGAGGATCCCTATGACCGG (BamHI)
SahH HTc R CTACTGAGTGCGGCCGCCCCGCGAGCAG (NotI)
SahH pSD5 F GGATGAAAGCCCATATGACCGGAAATTTGG (NdeI)
SahH pSD5 Rc ATTTTGCGTCTGCTCACGCGTGGGAGGCACTCAATGGTGATGGTGATGGTGGTAGCGGTAGTGG (MluI)
SahH pYUBDuet F AAGAAGGATGGATCCCCCTATGACCGGAAA (BamHI)
SahH pYUBDuet R TGGGCGATTTTGCGTAAGCTTGCGGGTGGGA (HindIII)
MsmSahH HTc F GAAAAAAGGGGGAATTCCATGACCGAACTCAAGGCCG (EcoRI)
MsmSahH HTc R GGGTTCCGGGGACTTAAGCTTGTCCGGGCTACCGGG (HindIII)
SahHT216A F GCCGAGTCGGTCAAGGGCGTCGCCGAGGAGACCACCACCGGCG
SahHT216A R CGCCGGTGGTGGTCTCCTCGGCGACGCCCTTGACCGACTCGGC
SahHT219A F CGGTCAAGGGCGTCACCGAGGAGGCCACCACCGGCGTGCTGCGG
SahHT219A R CCGCAGCACGCCGGTGGTGGCCTCCTCGGTGACGCCCTTGACCG
SahHT220A F CAAGGGCGTCACCGAGGAGACCGCCACCGGCGTGCTGCGGCTCTAC
SahHT220A R GTAGAGCCGCAGCACGCCGGTGGCGGTCTCCTCGGTGACGCCCTTG
SahHT221A F GGCGTCACCGAGGAGACCACCGCCGGCGTGCTGCGGCTCTACC
SahHT221A R GGTAGAGCCGCAGCACGCCGGCGGTGGTCTCCTCGGTGACGCC
SahHT219/220A F CAAGGGCGTCACCGAGGAGGCCGCCACCGGCGTGCTGCGGCTCTAC
SahHT219/220A R GTAGAGCCGCAGCACGCCGGTGGCGGCCTCCTCGGTGACGCCCTTG
SahHT219/220/221A F CAAGGGCGTCACCGAGGAGGCCGCCGCCGGCGTGCTGCGGCTCTAC
SahHT219/220/221A R GTAGAGCCGCAGCACGCCGGCGGCGGCCTCCTCGGTGACGCCCTTG
SahHT220/221A F CAAGGGCGTCACCGAGGAGACCGCCGCCGGCGTGCTGCGGCTCTAC
SahHT220/221A R GTAGAGCCGCAGCACGCCGGCGGCGGTCTCCTCGGTGACGCCCTTG
SahHT216/219/220/221A F TCGGTCAAGGGCGTCGCCGAGGAGGCCGCCGCCGGCGTGCTGCGGCTC
SahHT216/219/220/221A R GAGCCGCAGCACGCCGGCGGCGGCCTCCTCGGCGACGCCCTTGACCGA
SahHT257A F AAATTCGACAACAAGTACGGCGCTCGGCACTCCCTGATCGACGGC
SahHT257A R GCCGTCGATCAGGGAGTGCCGAGCGCCGTACTTGTTGTCGAATTT
SahHS376A F ACATGGCCGGGCTGGAGCGCGCCGGGGCGACACGGGTCAAC
SahHS376A R GTTGACCCGTGTCGCCCCGGCGCGCTCCAGCCCGGCCATGT
SahHH363A F GATCCTGGGAAATATCGGCGCCTTCGACAACGAGATCGAC
SahHH363A R GTCGATCTCGTTGTCGAAGGCGCCGATATTTCCCAGGATC
a‘F’ denotes forward primer and ‘R’ denotes reverse primer.
bRestriction sites/mutations are underlined and Restriction enzymes are mentioned in parenthesis.
cThis primer was used for addition of C-terminal His6-tag to the protein.
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analyzed in UCSF chimera12,49. Atoms were labeled using 2D labels in chimera tools
and Phosphate group was added by modifying atoms using chimera tools.
Analysis of proteins by two-dimensional PAGE. Recombinant proteins purified
from M. smegmatis MC2 4517 were desalted using chloroform/methanol
precipitation and 1 mg of both the proteins were resolved by two-dimensional PAGE
as described previously27. Isoelectric focusing was done using 7 cm IPG strips (Bio-
Rad) with 4–7 pH range, followed by second dimensional SDS-PAGE. After this,
proteins were transferred to nitrocellulosemembrane and immunoblotted using anti-
SahH antibodies.
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